Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SR VP, RESEARCH & DEVELOPMENT

SR VP, CORP OPERATIONS & LEGAL

SR VP, CLINICAL SCIENCE

PRESIDENT & CEO

Chief Scientific Officer

Chief Medical Officer & VP

COO & General Counsel

President & CEO

Chief Financial Officer

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial; and Lanraplenib, a next-generation SYK inhibitor to treat the patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-21	Premium	sold	Premium	Premium	Premium	SR VP, RESEARCH & DEVELOPMENT
2024-02-21	Premium	sold	Premium	Premium	Premium	SR VP, CORP OPERATIONS & LEGAL
2024-02-21	Premium	sold	Premium	Premium	Premium	SR VP, CLINICAL SCIENCE
2024-02-15	Premium	acquired	Premium	Premium	Premium	PRESIDENT & CEO
2024-01-04	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-01-04	Premium	sold	Premium	Premium	Premium	Chief Medical Officer & VP
2024-01-04	Premium	sold	Premium	Premium	Premium	COO & General Counsel
2023-12-12	Premium	sold	Premium	Premium	Premium	Chief Medical Officer & VP
2023-12-12	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-11-17	Premium	bought	Premium	Premium	Premium	President & CEO
2023-11-16	Premium	bought	Premium	Premium	Premium	President & CEO
2023-11-15	Premium	bought	Premium	Premium	Premium	President & CEO
2023-07-06	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-07-06	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-07-06	Premium	sold	Premium	Premium	Premium	Chief Medical Officer & VP
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-02-24	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-02-24	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-02-24	Premium	sold	Premium	Premium	Premium	Chief Medical Officer & VP
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-02-15	Premium	acquired	Premium	Premium	Premium	COO & General Counsel
2023-02-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer & VP
2022-12-12	Premium	sold	Premium	Premium	Premium	Chief Medical Officer & VP
2022-12-12	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer

KRON - Kronos Bio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for KRON